One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases.

One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases.
复制标题

DOI:
10.1016/j.vetpar.2020.109336
复制
发表时间:
2021-01
影响因子:
2.6
通讯作者:
Ojo KK
Ojo KK
中科院分区:
农林科学2区
文献类型:
--
作者:
Van Voorhis WC;Hulverson MA;Choi R;Huang W;Arnold SLM;Schaefer DA;Betzer DP;Vidadala RSR;Lee S;Whitman GR;Barrett LK;Maly DJ;Riggs MW;Fan E;Kennedy TJ;Tzipori S;Doggett JS;Winzer P;Anghel N;Imhof D;Müller J;Hemphill A;Ferre I;Sanchez-Sanchez R;Ortega-Mora LM;Ojo KK

文献摘要

参考文献

被引文献

相似文献

本文综述了近年来用于治疗顶复门寄生虫病的缓冲激酶抑制剂的研究进展。许多顶复门感染在人类和家畜之间共享,例如隐孢子虫病和弓形虫病,以及家畜特有的疾病,例如新孢子虫病。我们已经在隐孢子虫病(新生小牛感染隐孢子虫)、弓形虫病(妊娠绵羊感染弓形虫)和新孢子虫病(妊娠绵羊感染犬新孢子虫)的牲畜模型中证明了BKI治疗的概念验证。我们讨论了BKIs用于治疗动物和人类顶复门寄生虫引起的疾病的潜在用途,以及需要进一步开发BKIs的改进。
This is a review of the development of bumped-kinase inhibitors (BKIs) for the therapy of One Health parasitic apicomplexan diseases. Many apicomplexan infections are shared between humans and livestock, such as cryptosporidiosis and toxoplasmosis, as well as livestock only diseases such as neosporosis. We have demonstrated proof-of-concept for BKI therapy in livestock models of cryptosporidiosis (newborn calves infected with Cryptosporidium parvum), toxoplasmosis (pregnant sheep infected with Toxoplasma gondii), and neosporosis (pregnant sheep infected with Neospora caninum). We discuss the potential uses of BKIs for the treatment of diseases caused by apicomplexan parasites in animals and humans, and the improvements that need to be made to further develop BKIs.
DOI: 10.1016/s0140-6736(13)60844-2
发表时间: 2013-07-20
期刊: LANCET
影响因子: 168.9
作者:
Kotloff, Karen L.;Nataro, James P.;Levine, Myron M.
通讯作者: Levine, Myron M.
DOI: 10.1038/s41598-020-69078-9
发表时间: 2020-07-21
期刊: SCIENTIFIC REPORTS
影响因子: 4.6
作者:
Bigna, Jean Joel;Tochie, Joel Noutakdie;Nansseu, Jobert Richie
通讯作者: Nansseu, Jobert Richie
5岁以下儿童的腹泻感染与腹泻有关的发病率,死亡率和长期后果:一项荟萃分析研究。
DOI: 10.1016/s2214-109x(18)30283-3
发表时间: 2018-07
期刊: The Lancet. Global health
影响因子: --
作者:
Khalil IA;Troeger C;Rao PC;Blacker BF;Brown A;Brewer TG;Colombara DV;De Hostos EL;Engmann C;Guerrant RL;Haque R;Houpt ER;Kang G;Korpe PS;Kotloff KL;Lima AAM;Petri WA Jr;Platts-Mills JA;Shoultz DA;Forouzanfar MH;Hay SI;Reiner RC Jr;Mokdad AH
通讯作者: Mokdad AH
DOI: 10.1093/infdis/jiy664
发表时间: 2019-05-01
影响因子: 6.4
作者:
Hulverson, Matthew A.;Bruzual, Igor;Doggett, J. Stone
通讯作者: Doggett, J. Stone
DOI: 10.1074/jbc.m011045200
发表时间: 2001-04-13
影响因子: 4.8
作者:
Kieschnick, H;Wakefield, T;Beckers, C
通讯作者: Beckers, C